Sara Mohammadnejad Hamid Heidarzadeh Ellahe Bahrami- Vazir Azam Mohammadi

Keywords: Polycystic ovary syndrome, COVID-19, SARS-CoV-2, Vitamin D, Inflammation, Infertility

Abstract

Summary: COVID-19 has been associated with factors such as inflammation, obesity, low vitamin D levels, and hyperandrogenism. These factors are also directly related to Polycystic ovary syndrome (PCOS). We hypothesize that concurrent COVID-19 and high dose vitamin D supplement will decrease the inflammation, and can increase the chances of fertility in these women.

Key words: Polycystic ovary syndrome; COVID-19; SARS-CoV-2; Vitamin D; Inflammation; Infertility

Citation: Heidarzadeh H, Bahrami-Vazir E, Mohammadi A, Mohammadnejad S. Does vitamin D supplementation for COVID-19 increase the chances of fertility in women with polycystic ovary syndrome? Anaesth. pain intensive care 2022;26(4):574-575.

DOI: 10.35975/apic.v26i4.1969

Author Biographies

Sara Mohammadnejad

Faculty members, Department of Medical and Surgical Nursing, School of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran

Hamid Heidarzadeh

Faculty members, Department of Medical and Surgical Nursing, School of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Iran

Ellahe Bahrami- Vazir

Faculty members, Department of midwifery, Faculty of Nursing and Midwifery, Ilam University of Medical Sciences, Ilam, Islamic Republic of Iran;

Azam Mohammadi

Ph.D. Student in Reproductive Health, Department of Midwifery and Reproductive Health, Faculty of Nursing and midwifery, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran